Functional integrity of the CD28 co-stimulatory pathway in T lymphocytes from elderly subjects

Age and Ageing

Volumn 28, Issue 2, 1999, Pages 221-227

  Vidán, María T ^a   Fernández Gutiérrez, Benjamín ^a   Hernández García, César ^a   Serra, José A ^a   Ribera, José M ^a   Pérez Blas, Mercedes ^b   Regueiro, Jose R ^b   Bañares, Antonio ^a   Jover, Juan A ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

CD28; Elderly people; T cells

Indexed keywords

CD28 ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; MONOCLONAL ANTIBODY CD3; PHORBOL 13 ACETATE 12 MYRISTATE;

AGED; AGING; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CLONAL ANERGY; CONTROLLED STUDY; GENE EXPRESSION; GERONTOLOGY; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; SECRETION; STIMULUS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ADULT; AGED; AGING; ANTIGENS, CD28; CELL DIVISION; FEMALE; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-2; MALE; MITOGENS; RECEPTORS, INTERLEUKIN-2; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION, GENETIC;

EID: 17044449519     PISSN: 00020729     EISSN: None     Source Type: Journal    
DOI: 10.1093/ageing/28.2.221     Document Type: Article

References (65)

1. Adler WH, Nagel JE. Clinical immunology and ageing. In Hazzard WR, Andres R, Bierman ER, and Blass JP, eds. Principles of Geriatric Medicine and Gerontology. New York: McGraw-Hill, 1990.
2. Bender BS, Nagel JE, Adler WH, Andres R. Absolute peripheral blood lymphocyte count and subsequent mortality in elderly men. The Baltimore Longitudinal Study of Aging. J Am Geriatr Soc. 1986; 34: 649-54.
3. Doria G, Biozzi G, Mouton D, Covelli V. Genetic control of immune responsiveness, ageing and tumour incidence. Mech Ageing Dev 1997; 96: 1-13
4. Pawelec G, Adibzadeh M, Solana R, Beckman I. The T cell in the ageing individual. Mech Ageing Dev 1997; 93: 35-45.
5. hiCD4+T cells. Eur J Immunol. 1991; 21: 273-81.
6. Flurkey K, Stadecker M, Miller RA. Memory T lymphocyte hyporesponsiveness to non-cognate stimuli: a key factor in age related immunodeficiency. Eur J Immunol 1992; 22: 931-5.
7. Grubeck-Loebenstein B. Changes in the ageing immune system. Biologicals 1997; 25: 205-8.
8. Gabriel H, Schmitt B, Kindermann W. Age-related increase of CD45R0 lymphocytes in physically active adults. Eur J Immunol 1993; 23: 2704-6.
9. Miller RA. Immunodeficiency of ageing: restorative effects of phorbol ester combined with calcium ionophore. J Immunol 1986; 137: 805-8.
10. Ohkusu K, Du J, Isobe KI et al. Protein kinase C alpha-mediated chronic signal transduction for immunosenescence. J Immunol 1997; 159: 2082-4.
11. Negoro S, Hara H, Miyata S et al. Mechanism of age-related decline in antigen-specific T cell proliferative response of purified Tac-positive T cells. Mech Ageing Dev 1986; 36: 223-41.
12. Castle S, Uyemura K, Wong W, Modlin R, Effros R. Evidence of enhanced type 2 immune response and impaired upregulation of a type 1 response in frail elderly nursing home residents. Mech Ageing Dev 1997; 94: 7-16.
13. Bodnár Z, Steger MM, Saurwein-Teissl M, Maczek C, Grubeck-Loebenstein B. Cytokine production in response to stimulation with tetanus toxoid. Mycobacterium tuberculosis and influenza antigens in peripheral blood mononuclear cells and T cell lines from healthy elderlies. Int Arch Allergy Immunol 1997; 112: 323-30.
14. Whisler RL, Newhouse YG. Function of T cells from elderly humans: reductions of membrane events and proliferative responses mediated via T3 determinants and diminished elaboration of soluble T cell factors for B-cell growth. Cell. Immunol 1986; 99: 422-33.
15. Schwab R, Hausman PB, Rinnooy-Kan E, Weksler ME. Immunological studies of ageing. Impaired T lymphoytes and normal monocyte response from elderly humans to the mitogenic antibodies OKT3 and Leu4. Immunology 1985; 55: 677-84.
16. Rosemberg JS, Gilman SC, Feldman JD. Effects of ageing on cell co-operation and lymphocyte responsiveness to cytokines. J Immunol 1983; 130: 1754-8.
17. Gillis S, Kozak R, Durante M, Weksler ME. Immunological studies of ageing. Decreased production of and response to T cell growth factor by lymphocytes from aged humans. J Clin Invest 1981; 67: 937-42.
18. Shearer GM. Th1/Th2 changes in ageing. Mech Ageing Dev 1997; 94: 1-5.
19. Rudd CE. CD4, CD8, and the TCR-CD3 complex: a novel class of protein tyrosine kinase receptor. Immunol Today 1990; 11: 400-6.
20. Weiss A. T cell antigen receptor signal transduction: a tale of tails and cytoplasmic protein-tyrosine kinases. Cell 1993; 73: 209-12.
21. Mueller DL, Jenkins MK, Schwartz RH. Clonal expansion versus clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu Rev Immunol 1989; 7: 445-80.
22. Van Seventer GA, Shimizu Y, Shaw S. Roles of multiple accessory molecules in T cell activation. Curr Opin Immunol 1991; 13: 294-303.
23. De Silva DR, Urdahl KB, Jenkins MK. Clonal anergy is induced in vitro by T cell receptor occupancy in the absence of proliferation. J Immunol 1991; 147: 3261-7.
24. Jenkins MK. The role of cell division in the induction of clonal anergy. Immunol Today 1992; 13: 69-73.
25. Linsley PS, Ledbetter JA. The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 1993; 11: 191-211.
26. Johnson JG, Jenkins MK. Accessory cell-derived signals required for T cell activation. Immunol Res 1993; 12: 48-64.
27. Hansen JA, Martin PJ, Nowinski RC. Monoclonal antibodies identifying a novel T cell antigen and Ia antigens of human lymphocytes. Immunogenetics 1980; 10: 247-52.
28. June CH, Ledbetter JA, Gillespie MM, Lindsten T, Thompson CB. T cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression. Mol Cell Biol 1987; 7: 4472-81.
29. Gross JA, St John T, Allison JP. The murine homologue of T lymphocyte antigen CD28. Molecular cloning and cell surface expression. J Immunol 1990; 144: 3201-10.
30. Freeman GJ, Borriello F, Hodes RJ et al. Uncovering of functional alternative CTLA-4 counter-receptor in B-7 deficient mice. Science 1993; 262: 907-9.
31. Boussiotis VA, Freeman GJ, Gribben JG, Daley J, Gray G, Nadler LM. Activated human B lymphocytes express three CTLA-4 counter-receptors that costimulate T cell activation. Proc Natl Acad Sci USA 1993; 90: 11059-63.
32. Lenschow DJ, Su GH, Zuckerman LA et al. Expression and functional significance of and additional ligand for CTLA4. Proc Natl Acad Sci USA 1993; 90: 11054-8.
33. Hatchcock KS, Laszlo G, Dickler HB, Bradshaw J, Linsley P, Hodes RJ. Identification of an alternative CTLA-4 ligand costimulatory for T cell activation. Science 1993; 262: 905-7.
34. Freeman GJ, Gribben JG, Boussiotis VA et al. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 1993; 262: 909-11.
35. Azuma M, Yssel H, Philips JH, Spits H, Lanier LL. Functional expression of B7/BB1 on activated T lymphocytes. J Exp Med 1993; 177: 845-50.
36. Sansom DM, Hall ND. B7/BB-1, the ligand for CD28 is expressed on repeatedly activated human T cells in vitro. Eur J Immunol 1993; 23: 295-8.
37. Harper K, Balzano C, Rouvier E, Mattei MG, Luciani MF, Goldstein P. CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence message expression, gene structure and chromosomal location. J Immunol 1991; 147: 1037-44.
38. Lafage-Pochitaloff M, Costello R, Couez D et al. Human CD28 and CTLA-4 Ig superfamily genes are located on chromosome 2 at bands q33-q34. Immunogenetics 1990; 31: 198-201.
39. June CH, Bluestone JA, Nadler LM, Thompson CB. The B7 and CD28 receptor families. Immunol Today 1994; 15: 321-31.
40. Azuma M, Ito D, Yagita H et al. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 1993; 366: 76-9.
41. June CH, Ledbetter JA, Gillespie MM, Lindsten T, Thompson CB. T cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression. Mol Cell Biol 1987; 7: 4472-81.
42. Ledbetter JA, Parsons M, Martin PJ, Hansen JA, Ravinovitch PS, June CH. Antibody binding to CD5 (Tp67) and Tp44 T cell surface molecules: effects on cyclic nucleotides, cytoplasmic free calcium and cAMP-mediated suppression. J Immunol 1986; 137: 3299-305.
43. Jenkins MK, Taylor PS, Norton SD, Urdahl KB. CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells. J Immunol 1991; 147: 2461-6.
44. Harding FA, McArthur JG, Gross JA, Raulet DH, Allison JP. CD28 mediated signalling costimulates murine T cells and prevents induction of anergy in T cell clones. Nature 1992; 356: 607-9.
45. Ligthart GJ, Corberand JX, Fournier C et al. Admission criteria for immunological studies in man: the SENIEUR protocol. Mech Ageing Dev 1984; 28: 47-55.
46. Gottlieb AB, Fu SM, Yu DTY, Wang CY, Halper JP, Kunkel HG. The nature of the stimulatory cell in human allogeneic and autologous MLC reactions; role of isolated IgM-bearing B cells. J Immunol 1979; 123: 1497-502.
47. Cantrell DA, Smith KA. The interleukin-2 T cell system: a new cell growth model. Science 1984; 224: 1312-6.
48. Fraser JD, Irving BA, Crabtree GR, Weiss A. Regulation of intreleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science 1991; 251: 313-6.
49. Lindsten T, June CH, Ledbetter JA, Stella G, Thompson CB. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 1989; 244: 339-43.
50. Thompson CB, Lindsten T, Ledbetter JA et al. CD28 activation pathway regulates the production of multiple T cell derived lymphokines/cytokines. Proc Natl Acad Sci USA 1989; 86: 1333-7.
51. Liu Y, Linsley PS. Costimulation and T cell growth. Curr Opin Immunol 1992; 4: 265-70.
52. Engwerda CH, Handwerger BS, Fox BS. Aged T cells are hyporesponsive to costimulation mediated by CD28. J Immunol 1994; 152: 3740-7.
53. Matour D, Melnikoff M, Kaye D, Murasko DM. The role of cell phenotype in decreased lymphoproliferation of the elderly. Clin Immunol Immunopathol 1989; 50: 82-9.
54. Sansoni P, Cossarizza A, Brianti V et al. Lymphocyte subsets and natural killer activity in healthy old people and centenarians. Blood 1993; 82: 2767-73.
55. Mascart-Lemone F, Delespesse G, Servais G, Kuntsler M. Characterization of immunoregulatory T lymphocytes during ageing by monoclonal antibodies. Clin Exp Immunol 1982; 48: 148-54.
56. Nagel JA, Chrest FJ, Adler WH. Enumeration of T lymphocyte subsets by monoclonal antibodies in young and aged humans. J Immunol 1981; 127: 2086-8.
57. -T cells are expanded in rheumatoid arthritis and are characterised by autoreactivity. J Clin Invest 1996; 97: 2027-37.
58. + T cells in severe rheumatoid arthritis. Arthritis and Rheumatism 1997; 40: 1106-14.
59. +CD28 T cells. Fifth EUCAMBIS Congress on the Molecular Biology of Immunosenescence. Córdoba, Spain, 1997.
60. Chopra RK, Holbrook NJ, Powers DC, McCoy MT, Adler WH, Nagel JE. Interleukin 2, interleukin 2 receptor, and interferon γ synthesis and mRNA expression in phorbol myristate acetate and calcium ionophore A23187-stimulated T cells from elderly humans. Clin Immunol Immunopathol 1989; 53: 297-308.
61. Nagel JE, Chopra RK, Chrest FJ, McCoy MT, Schneider EL. Decreased proliferation, interleukin 2 synthesis, and interleukin 2 receptor expression are accompanied by decreased mRNA expression in phytohemagglutinin-stimulated cells from elderly donors. J Clin Invest 1988; 81: 1096-102.
62. Cerdan C, Martin Y, Courcoul M et al. Prolonged IL-2 receptor/ CD25 expression after T cell activation via the adhesion molecules CD2 and CD28. Demonstration of combined transcriptional and post-transcriptional regulation. J Immunol 1992; 149: 2255-61.
63. Huang YP, Pechere JC, Michel M et al. In vivo T cell activation, in vitro defective IL-2 secretion, and response to influenza vaccination in elderly women. J Immunol 1992; 148: 715-22.
64. Koretzky GA, Picus J, Schultz T, Weiss A. Tyrosine phosphatase CD45 is required for T cell antigen receptor and CD2-mediated activation of a protein tyrosine kinase and interleukin 2 production. Proc Natl Acad Sci USA 1991; 88: 2037-41.
65. Leitenberg D, Novak TJ, Farber D, Smith BR, Bottomly K. The extracellular domain of CD45 controls association with the CD4-T cell receptor complex and the response to antigen-specific stimulation. J Exp Med 1996; 183: 249-59.